232 related articles for article (PubMed ID: 15611237)
1. Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes.
Duthoit CT; Mekala DJ; Alli RS; Geiger TL
J Immunol; 2005 Jan; 174(1):155-63. PubMed ID: 15611237
[TBL] [Abstract][Full Text] [Related]
2. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes.
Inaba H; Geiger TL
Int Immunol; 2006 Jul; 18(7):1043-54. PubMed ID: 16702166
[TBL] [Abstract][Full Text] [Related]
3. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
Grundström S; Dohlsten M; Sundstedt A
J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
[TBL] [Abstract][Full Text] [Related]
4. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.
Koenen HJ; Fasse E; Joosten I
J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842
[TBL] [Abstract][Full Text] [Related]
5. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.
Burchill MA; Goetz CA; Prlic M; O'Neil JJ; Harmon IR; Bensinger SJ; Turka LA; Brennan P; Jameson SC; Farrar MA
J Immunol; 2003 Dec; 171(11):5853-64. PubMed ID: 14634095
[TBL] [Abstract][Full Text] [Related]
7. Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms.
Wolf M; Schimpl A; Hünig T
Eur J Immunol; 2001 Jun; 31(6):1637-45. PubMed ID: 11385607
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
9. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
Antov A; Yang L; Vig M; Baltimore D; Van Parijs L
J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.
Piccirillo CA; Shevach EM
J Immunol; 2001 Aug; 167(3):1137-40. PubMed ID: 11466326
[TBL] [Abstract][Full Text] [Related]
11. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
12. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.
Thornton AM; Shevach EM
J Immunol; 2000 Jan; 164(1):183-90. PubMed ID: 10605010
[TBL] [Abstract][Full Text] [Related]
13. Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment.
Yamane H; Zhu J; Paul WE
J Exp Med; 2005 Sep; 202(6):793-804. PubMed ID: 16172258
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
Park HB; Paik DJ; Jang E; Hong S; Youn J
Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
[TBL] [Abstract][Full Text] [Related]
15. Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.
Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Boot EP; Lin CH; Arkesteijn GJ; van Eden W; Taams LS; Wauben MH
Eur J Immunol; 2004 Nov; 34(11):3016-27. PubMed ID: 15376196
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
Thornton AM; Shevach EM
J Exp Med; 1998 Jul; 188(2):287-96. PubMed ID: 9670041
[TBL] [Abstract][Full Text] [Related]
17. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy.
Ermann J; Szanya V; Ford GS; Paragas V; Fathman CG; Lejon K
J Immunol; 2001 Oct; 167(8):4271-5. PubMed ID: 11591749
[TBL] [Abstract][Full Text] [Related]
18. Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activation.
Teague RM; Tempero RM; Thomas S; Murali-Krishna K; Nelson BH
J Immunol; 2004 Sep; 173(5):3131-9. PubMed ID: 15322173
[TBL] [Abstract][Full Text] [Related]
19. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15.
Campbell JD; Cook G; Robertson SE; Fraser A; Boyd KS; Gracie JA; Franklin IM
J Immunol; 2001 Jul; 167(1):553-61. PubMed ID: 11418694
[TBL] [Abstract][Full Text] [Related]
20. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
